Get started
Nektar Therapeutics
Long

NKTR Risky LONG Trade

By MCFX88
Updated
Although this seems to be a risky long trade. The reward is looking promising. Looking at the fundamentals, this company is well positioned with Cash. Debt is manageable even though the company is burning through cash (but that what most healthcare companies do until their products get FDA approval). Targets and Stops are in the graphic.
Trade active
Trade active
Trade active
Chart PatternshealthcareTechnical IndicatorsnasdaqstockmarketsStocksTrend Analysis
MCFX88
Also on:

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.